Perpetua Medical ABPPTMF 57 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates PPTMF with a GF Score™ of 57/100 and a GF Value™ of $1.15. The stock has 6 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Perpetua Medical AB ranks better than 99.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Perpetua Medical AB's annualized net income for the quarter that ended in Mar. 2026 was $-0.89 Mil. Perpetua Medical AB's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-0.40 Mil. Therefore, Perpetua Medical AB's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.
The historical rank and industry rank for Perpetua Medical AB's Return-on-Tangible-Equity or its related term are showing as below:
PPTMF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -343.73 Med: -118.66 Max: -62.25
Current: Negative Tangible Equity
During the past 12 years, Perpetua Medical AB's highest Return-on-Tangible-Equity was -62.25%. The lowest was -343.73%. And the median was -118.66%.
PPTMF's Return-on-Tangible-Equity is ranked better than 99.87% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.09
vs PPTMF: Negative Tangible Equity
Perpetua Medical AB (OTCPK:PPTMF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Perpetua Medical AB Return-on-Tangible-Equity Related Terms
Perpetua Medical AB Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Perpetua Medical AB's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perpetua Medical AB Return-on-Tangible-Equity Chart
PPTMF vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Perpetua Medical AB's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perpetua Medical AB Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Perpetua Medical AB's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Perpetua Medical AB (PPTMF) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Perpetua Medical AB and its competitors. According to the industry distribution chart, Perpetua Medical AB ranks #1 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 0.099999999999994%.
Is Perpetua Medical AB's Return-on-Tangible-Equity too high?
Perpetua Medical AB's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Perpetua Medical AB ranks #1 out of 757 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Perpetua Medical AB has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perpetua Medical AB ranks #1 out of 757 companies for Return-on-Tangible-Equity. This places Perpetua Medical AB in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.09, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Perpetua Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perpetua Medical AB's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Perpetua Medical AB (PPTMF) has a current Return-on-Tangible-Equity of 0.00%. The stock's GF Value™ is $1.15, compared to a current price of $1.08 — trading 6.2% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Perpetua Medical AB's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Perpetua Medical AB (PPTMF), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perpetua Medical AB (PPTMF) Overvalued in 2026?
Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued.
The current stock price of $1.08 is trading 6.2% below its estimated GF Value™ of $1.15.
Key valuation signals for PPTMF:
Return-on-Tangible-Equity: 0.00%
GF Value™: $1.15 vs. price of $1.08 (6.2% below fair value)
No single metric tells the full story. See the PPTMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
57GF Score
Get the complete analysis for PPTMF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPTMF has been successfully added to your 
